Altorjay A, Juhasz A, Kellner V, Sohar G, Fekete M, Sohar I. Metabolic changes in the lower esophageal sphincter influencing the result of anti-reflux surgical interventions in chronic gastroesophageal reflux disease. World J Gastroenterol 2005; 11(11): 1623-1628 [PMID: 15786538 DOI: 10.3748/wjg.v11.i11.1623]
Corresponding Author of This Article
Aron Altorjay M.D., Ph.D., Professor of Surgery, Department of Surgery, Saint George University Teaching Hospital, Seregélyesi u. 3., Székesfehérvár, H-8000, Hungary. altorjay@mail.fmkorhaz.hu
Article-Type of This Article
Brief Reports
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Mar 21, 2005; 11(11): 1623-1628 Published online Mar 21, 2005. doi: 10.3748/wjg.v11.i11.1623
Table 1 Metabolic enzyme activities and special protein concentrations in normal LES and in LES operated due to gastroesophageal reflux, as well as in patients with and without complaints in the postoperative period.
Enzymes
LES
P
LES in GERD
P
Normal
GERD
Visick I
Visick II–III
Mean
SE
Mean
SE
Mean
SE
Mean
SE
CK
73027.3
32312.4
398220.7
210587.2
P<0.05
111904.3
29131.0
1098105.3
514604.5
P<0.001
LDH
23805.7
9561.9
127786.9
62210.7
P<0.05
44229.0
7850.8
332039.5
54804.5
P<0.001
HBDH
7960.3
3159.9
41400.3
20129.8
P<0.05
13906.0
2588.4
105553.7
47629
P<0.001
AST
2869.5
1453.0
13397.2
6825.7
P<0.05
3697.0
923
36030.9
14938.4
P<0.001
CK-MB
269.1
103.9
1580.3
1332.6
NS
597.5
185.3
3655.2
4374.7
NS
S-100
1252.5
844
10569.1
5038.1
P<0.05
3986.5
2123.0
26018.5
11485.7
P<0.001
MYO
750.3
538.3
11339.8
14029.3
NS
2395.8
1268.1
32581.8
52349.6
P<0.05
TNI
0.17
0.08
1.56
0.78
P<0.05
0.68
0.24
3.93
2.25
P<0.001
Table 2 Lysosomal enzyme activities in normal LES and in LES operated due to gastroesophageal reflux, as well as in patients with and without complaints in the postoperative period.
Enzymes
LES
P
LES in GERD
P
Normal
GERD
Visick I
Visick II–III
Mean
SE
Mean
SE
Mean
SE
Mean
SE
CB
14177.5
3441.9
7727.6
1913.9
P<0.001
6442.8
2242.7
10439.8
3548.1
P<0.05
TPP I
74318.0
10742.6
47509.9
5339.3
P<0.001
47541.6
6760.4
47438.5
11067.2
NS
DPP II
3970.4
1189.3
2513.3
512
P<0.001
2860.7
647.1
1779.7
744.1
P<0.05
HEX
17253.7
4457.9
9185.0
1604.7
P<0.001
9528.2
2267.2
8460.4
2054.9
NS
GCU
17345.0
5145.4
13123.5
2307.5
NS
13980.1
3263.8
11315.2
2541.3
NS
BMAN
4207.5
1246.1
2922.9
587.7
P<0.05
3248.4
824.1
2235.9
481.4
NS
AMAN
962.4
726.8
469.9
172.2
NS
567.4
232.8
238.5
108.9
NS
BGAL
17714.3
3561.0
11396.7
1567.3
P<0.001
11733.9
2241.9
10684.9
1821.4
NS
Table 3 Metabolic enzyme ratios in normal LES and in LES operated due to gastroesophageal reflux, as well as in patients with and without complaints in the postoperative period.
Enzymes
LES
P
LES in GERD
P
Normal
GERD
Visick I
Visick II–III
Mean
SE
Mean
SE
Mean
SE
Mean
SE
HBDH/LDH
0.337
0.009
0.319
0.006
P<0.001
0.321
0.009
0.318
0.008
NS
CK-MB/CK
0.005
0.003
0.006
0.003
NS
0.006
0.003
0.005
0.007
NS
Table 4 Patient satisfaction index according to Visick in the 2nd and 12th postoperative months of 31 patients who had laparoscopic floppy Nissen type operation due to gastroesophageal reflux disease.
Visick
2 (mo, %)
12 (mo, %)
I Symptoms-free
22 (71)
27(87)
II Mild symptoms
8 (26)
- Dysphagia
6/8
3 (10)
- Dysphagia
2/3
- Bloating
3/8
- Bloating
2/3
- Epigastric pain
2/8
Heartburn
1/3
III Can be treated with medication or with dilation
1 (3)
- Dysphagia
1 (3)
- Dysphagia
- Heartburn
- Heartburn
- Belching
- Belching
IV Reoperation needed
-
-
Citation: Altorjay A, Juhasz A, Kellner V, Sohar G, Fekete M, Sohar I. Metabolic changes in the lower esophageal sphincter influencing the result of anti-reflux surgical interventions in chronic gastroesophageal reflux disease. World J Gastroenterol 2005; 11(11): 1623-1628